AI Article Synopsis

Article Abstract

Objective: To investigate the expression changes of miRNAs (miR199a-5P, miR206, miR133a-3P, miR499-5P) in rat model of cardiac hypertrophy induced by isoproterenol (ISO), and to explore the main signal pathways and molecular mechanisms which related to that with the way of bioinformatics.

Methods: Sixteen SD male rats were randomly divided into two groups: control group and ISO model group. The rats in model group were treated with ISO (1 mg/kg) to induce cardiac hypertrophy, the rats in control group were treated with the same amount of saline, and all were injected subcutaneously at the back. After 10 days of continuous administration, interventricular septal thickness at diastole (IVSd), left ventricular posterior wall thickness at diastole (LVPWd) , left ventricular end-diastolic diameter(LVDd), and systolic function (EF%) were measured by echocardiography. Heart weight (HW) and rat body weight (BW) were weighed, and heart/body weight ratio (HW/BW) was calculated. Myocardial tissues were stained with HE, and myocardial cell surface area was measured by Image J analysis software; RT-qPCR was used to detect the expressions of 4 miRNAs in rat myocardial tissues. Targetscan, miRDB and miRwalk databases were used to predict the possible target genes of four kinds of miRNAs in rats, and FunRich software was used to analyze and predict the signal pathways related to the target genes.

Results: Compared with the control group, the IVSd and LVPWd in the model group were thickened, the LV was increased, and the EF% was decreased significantly. The HW and HW/BW were increased. The myocardial cell volume in the model group was increased significantly, the arrangement was disordered, and the cell surface area was increased; the expressions of miR199a-5P and miR206 in the model group were up-regulated by RT-qPCR (P<0.05); the expressions of miR133a-3P and miR499-5P were down-regulated (P<0.05). Predicted by bioinformatics application, related signal pathways which target genes of 4 miRNAs maybe involved in cardiac hypertrophy mainly are: VEGF/VEGFR signal pathway, ErbB receptor signal pathway and other signal pathways.

Conclusion: ISO-induced cardiac hypertrophy leads to changes in miRNA expression, and bioinformatics predicts related target genes of four miRNAs involved in cardiac hypertrophy and their major signaling pathways. These studies will provide new ideas for the regulation of cardiac hypertrophy and its prevention and treatment measures.

Download full-text PDF

Source
http://dx.doi.org/10.12047/j.cjap.5835.2019.104DOI Listing

Publication Analysis

Top Keywords

cardiac hypertrophy
24
model group
20
signal pathways
12
control group
12
target genes
12
mir199a-5p mir206
8
mir133a-3p mir499-5p
8
group
8
group treated
8
thickness diastole
8

Similar Publications

Background: Diabetes mellitus is associated with morphological and functional impairment of the heart primarily due to lipid toxicity caused by increased fatty acid metabolism. Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) have been implicated in the metabolism of fatty acids in the liver and skeletal muscles. However, their role in the heart in diabetes remains unclear.

View Article and Find Full Text PDF

Syringaldehyde Alleviates Cardiac Hypertrophy Induced by Hyperglycemia in H9c2 Cells Through GLP-1 Receptor Signals.

Pharmaceuticals (Basel)

January 2025

Department of Pharmacy, College of Pharmacy and Health Care, Tajen University, Pingtung 90741, Taiwan.

Cardiac hypertrophy is a significant complication of diabetes, often triggered by hyperglycemia. Glucagon-like peptide-1 (GLP-1) receptor agonists alleviate cardiac hypertrophy, but their efficacy diminishes under GLP-1 resistance. Syringaldehyde (SA), a natural phenolic compound, may activate GLP-1 receptors and mitigate hypertrophy.

View Article and Find Full Text PDF

Background: Myocardial disease is an important component of the wide field of cardiovascular disease. However, the phenomenon of multiple myocardial diseases in a single patient remains understudied.

Aim: To investigate the prevalence and impact of myocarditis in patients with genetic cardiomyopathies and to evaluate the outcomes of myocarditis treatment in the context of cardiomyopathies.

View Article and Find Full Text PDF

Baicalin Mitigates Cardiac Hypertrophy and Fibrosis by Inhibiting the p85a Subunit of PI3K.

Biomedicines

January 2025

Department of Biochemistry and Molecular Biology, School of Basic Medicine and the Collaborative Innovation Center for Brain Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Heart failure (HF) is a serious public health concern. Baicalin is one of the major active ingredients of a traditional Chinese herbal medicine, Huang Qin, which is used to treat patients with chest pain or cardiac discomfort. However, the underlying mechanism(s) of the cardioprotective effect of baicalin are still not fully understood.

View Article and Find Full Text PDF

: Aging is associated with structural and functional changes in the heart, including hypertrophy, fibrosis, and impaired contractility. Cellular mechanisms such as senescence, telomere shortening, and DNA damage contribute to these processes. Nuclear factor kappa B (NF-κB) has been implicated in mediating cellular responses in aging tissues, and increased NF-κB expression has been observed in the hearts of aging rodents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!